-
Annual General Meeting
Mebo Pharmaceutical (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
-
Balance Sheet
Progress on Mebo Pharmaceutical (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
-
Director Appointment
The activity Yun Wu was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 2 months . was completed.
-
Director Appointment
Vipul Thapliyal was appointed as a Director was appointed as a Director on 14 Aug 2014 & has been associated with this company since 11 years 5 months . was recorded as a recent event.
-
Director Appointment
Gang Liu was appointed as a Director was appointed as a Director on 26 Apr 2011 & has been associated with this company since 14 years 8 months . was recorded as a recent event.
-
Company Incorporation
The activity Mebo Pharmaceutical (India) Private Limited was registered on 26 Apr 2011 with Roc Delhi & aged 14 years 8 months as per MCA records. was completed.
Mebo Pharmaceutical (India) Private Limited, a active private limited company, was established on 26 April 2011 in New Delhi, Delhi, India. Engaging in business & it consulting within the trade sector, it holds CIN: U24232DL2011PTC218125. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Gang Liu (Director), Vipul Thapliyal (Director), Yun Wu (Director). Past directors included Xia Sun, Vipul Thapliyal. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.918 & 919, Ninth Floor, Westend Mall, District Center, Janakpuri,, New Delhi, Delhi, 110058.
Company Details
- CIN/LLPIN
U24232DL2011PTC218125
- Registration Number
218125
- Incorporation Date
26 April 2011
- Authorized Capital
₹0.50 M
- Paid-Up Capital
₹0.50 M
- ROC Code
Roc Delhi
-
Listing Status
Unlisted
- Company Status
Active
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -30.66%
- Profit Growth -21.25%
- Ebitda -5.21%
- Net Worth 133.12%
- Total Assets -16.52%
Mebo Pharmaceutical (India) Private Limited
Company Report FY 2025-2026Comprehensive Company Insights
Explore comprehensive insights into Mebo Pharmaceutical (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gang Liu | Director | 26 Apr 2011 | Current |
| Vipul Thapliyal | Director | 14 Aug 2014 | Current |
| Yun Wu | Director | 05 Nov 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Nov 2014 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mebo Pharmaceutical (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.66% decrease. The company also saw a substantial fall in profitability, with a 21.25% decrease in profit. The company's net worth Soared by an impressive increase of 133.12%.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
Unlock access to Mebo Pharmaceutical (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
-
Promoters: 92.83%
-
Public: 4.10%
-
Others: 3.07%
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
Unlock and access historical data on people associated with Mebo Pharmaceutical (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Mebo Pharmaceutical (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mebo Pharmaceutical (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
What is the CIN of Mebo Pharmaceutical (India) Private Limited?
The CIN of Mebo Pharmaceutical (India) Private Limited is U24232DL2011PTC218125.
Where is Mebo Pharmaceutical (India) Private Limited headquartered?
Mebo Pharmaceutical (India) Private Limited is headquartered at No.918 & 919, Ninth Floor, Westend Mall, District Center, Janakpuri,, New Delhi, Delhi, 110058.
When was Mebo Pharmaceutical (India) Private Limited incorporated?
Mebo Pharmaceutical (India) Private Limited was incorporated on 26 April 2011.
Who are the current directors of Mebo Pharmaceutical (India) Private Limited?
The current directors of Mebo Pharmaceutical (India) Private Limited are
What is the primary industry of Mebo Pharmaceutical (India) Private Limited?
The primary industry of Mebo Pharmaceutical (India) Private Limited is Trade.
Is Mebo Pharmaceutical (India) Private Limited a listed company?
Mebo Pharmaceutical (India) Private Limited is unlisted.
What is the capital structure of Mebo Pharmaceutical (India) Private Limited?
The authorized capital of Mebo Pharmaceutical (India) Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
What is the compliance status of Mebo Pharmaceutical (India) Private Limited?
The compliance status of Mebo Pharmaceutical (India) Private Limited is Compliant.
+91-XXXXXXXXXX